Mylan Pharmaceuticals Inc. et al. v. Bausch Health Ireland Limited et al. > Summary
Court Case Number IPR2022-01103
Filing Date Jun 10, 2022
Institution Decision Date Jan 4, 2023
Decision Date Jan 4, 2023
Court Patent Trial and Appeal Board
Status Institution Denied
Administrative JudgesMichael Valek, Sheridan K. Snedden, Cynthia M. Hardman
Judge Writing the Final DecisionMichael Valek
Claims Challenged in the Petition: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
Petitioner
Patent Owner
Petitioner Attorneys
5Viatris Inc.
Attorney Name: Jad Allen Mills
Wilson Sonsini Goodrich & Rosati
Viatris Inc.
Attorney Name: Dennis D. Gregory
Wilson Sonsini Goodrich & Rosati
Viatris Inc.
Attorney Name: Richard L. Torczon Jr.
Wilson Sonsini Goodrich & Rosati
Viatris Inc.
Attorney Name: Nicole W. Stafford
Wilson Sonsini Goodrich & Rosati
Viatris Inc.
Attorney Name: Graham Buckton
University College London, University of London
Patent Owner Attorneys
7Bausch Health Companies
Attorney Name: Justin J. Hasford
Finnegan, Henderson, Farabow, Garrett & Dunner
Bausch Health Companies
Attorney Name: Geneva Eaddy
Finnegan, Henderson, Farabow, Garrett & Dunner
Bausch Health Companies
Attorney Name: Joshua L. Goldberg
Finnegan, Henderson, Farabow, Garrett & Dunner
Bausch Health Companies
Attorney Name: Kyu Yun Kim
Finnegan, Henderson, Farabow, Garrett & Dunner
Bausch Health Companies
Attorney Name: Lauren J. Robinson
Finnegan, Henderson, Farabow, Garrett & Dunner
Bausch Health Companies
Attorney Name: Caitlin E. O'Connell
Finnegan, Henderson, Farabow, Garrett & Dunner
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 09616097 | Formulations of guanylate cyclase C agonists and methods of use | Apr 11, 2017 |
